CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Hugel Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Hugel Inc
23, Geodudanji 1-gil, Dongnae-myeon
Phone: +82 269661600p:+82 269661600 CHUNCHEON, 24398  South Korea Ticker: 145020145020
Business Summary
Hugel Inc is a Korea-based company mainly engaged in the manufacture and sale of biopharmaceutical products in the medical aesthetics field. The Company is mainly engaged in the research, development, manufacturing, and sales of biopharmaceuticals utilizing type A botulinum toxin derived from the microorganism Clostridium botulinum, as well as hyaluronic acid–based tissue-restoration biomaterial filler products. In addition, the company sells botulinum toxin products, hyaluronic acid fillers, cosmetics, skin boosters, and lifting threads. The Company sells its products in domestic and overseas markets.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202512/31/2025Yes----

Industries
SIC Code Description
2836 Biological products, except diagnostic substances
3845 Electromedical and electrotherapeutic apparatus
2844 Perfumes, cosmetics, and other toilet preparations
6512 Operators of nonresidential buildings

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Other Non-Executive Chairman Seok YongCha 72 3/30/2023 3/30/2023
Chief Executive Officer Du HyeonJang 49 9/15/2025 9/15/2025
Managing Director Seung WukChi 49 1/1/2024 1/1/2022
12 additional Officers and Directors records available in full report.

General Information
Number of Employees: 126 (As of 12/31/2015)
Outstanding Shares: 10,803,292 (As of 12/31/2025)
Shareholders: 19,562
Stock Exchange: KDQ
Fax Number: +82 269661691


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, March 24, 2026